ID   NCC-DFSP4-C1
AC   CVCL_D1GH
DR   Wikidata; Q127382927
RX   PubMed=37490236;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 39 hours (Note=At 22th passage) (PubMed=37490236).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Left ilium, hypodermis; UBERON=UBERON_0001273+UBERON_0002072.
ST   Source(s): PubMed=37490236
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10,13
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
RX   PubMed=37490236; DOI=10.1007/s13577-023-00932-4;
RA   Akiyama T., Yoshimatsu Y., Noguchi R., Sin Y., Osaki J., Ono T.,
RA   Adachi Y., Tsuchiya R., Toda Y., Ogura K., Kojima N., Yoshida A.,
RA   Ohtori S., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-DFSP4-C1: a novel cell line
RT   from a patient with dermatofibrosarcoma protuberans having the
RT   fibrosarcomatous transformation.";
RL   Hum. Cell 36:2187-2194(2023).
//